Impeding estrogens and the etiology of breast cancer.
D015127:9,10-Dimethyl-1,2-benzanthracene; D000818:Animals; D000906:Antibodies / Q000008:administration & dosage; D010064:Embryo Implantation / Q000187:drug effects; D004958:Estradiol / Q000276:immunology / Q000494:pharmacology; D045166:Estradiol Congeners / Q000494:pharmacology*; D004964:Estriol / Q000031:analogs & derivatives / Q000494:pharmacology*; D004965:Estrogen Antagonists; D005260:Female; D006801:Humans; D006894:Hydroxyestrones / Q000494:pharmacology; D008325:Mammary Neoplasms, Experimental / Q000209:etiology*; D009929:Organ Size / Q000187:drug effects; D011247:Pregnancy; D011817:Rabbits; D051381:Rats; D011980:Receptors, Progesterone / Q000096:biosynthesis / Q000187:drug effects; D014599:Uterus / Q000187:drug effects
D000906:Antibodies; D045166:Estradiol Congeners; D004965:Estrogen Antagonists; D006894:Hydroxyestrones; D011980:Receptors, Progesterone; D004958:Estradiol; D015127:9,10-Dimethyl-1,2-benzanthracene; D004964:Estriol